Novavax (NSDQ:NVAX) today announced that it has begun its first Phase 3 study to evaluate the efficacy, safety and immunogenicity of its COVID-19 vaccine candidate, NVX-CoV2373. The trial is underway in the UK, in partnership with the UK government’s Vaccines Taskforce. Gaithersburg, Md.-based Novavax said it expects to enroll up to 10,000 individuals between 18 and […]
Report: AstraZeneca Phase III COVID-19 vaccine remains on hold in U.S.
AstraZeneca (NYSE:AZN) is reportedly keeping its COVID-19 vaccine trial in the U.S. on hold as questions remain over patient safety. U.S. Health and Human Services Dept. Secretary Alex Azar told CNBC yesterday that federal investigators are looking for “answers to important questions,” regarding the safety of patients involved in the trial operated by the United Kingdom-based company in […]
Dexcom inks 5-year diabetes research pact with U of Virginia
Dexcom (NSDQ:DXCM) announced today that it signed a five-year collaboration agreement with the University of Virginia for CGM research. The partnership will focus on advancing Dexcom’s automated insulin delivery technology and exploring the use of continuous glucose monitoring (CGM) tools outside the Type 1 diabetes market, which includes inpatient hospital use, Type 2 diabetes and gestational […]
J&J launches fourth large-scale COVID-19 vaccine trial
Johnson & Johnson (NYSE:JNJ) has begun enrollment of adult volunteers for a fourth Phase 3 clinical trial of a COVID-19 vaccine candidate. The National Institutes of Health announced today that J&J’s Janssen Pharmaceuticals COVID-19 vaccine candidate (JNJ-78436725) has begun the Phase 3 trial to evaluate if it can prevent symptomatic COVID-19 after a single dose regimen. Up […]
Medtronic touts savings of using antibacterial ‘envelope’
Medtronic (NYSE:MDT) is touting new data from its WRAP-IT study demonstrating the cost-effectiveness of its TYRX absorbable antibacterial envelope. Fridley, Minn.-based Medtronic designed its TYRX absorbable antibacterial envelope for patients at increased risk of infections who receive cardiac implantable electronic devices (CIEDs). Results from the WRAP-It study, published in Circulation: Arrhythmia and Electrophysiology, showcase the cost-effectiveness […]
Anthem, Apple to launch asthma study
Anthem (NYSE:ANTM) announced today that it is collaborating with Apple (NSDQ:AAPL) on a study using smart devices to manage asthma. Indianapolis-based Anthem and Apple are planning on examining how the use of everyday devices like the Apple Watch and iPhone can help individuals with asthma better self-manage their condition in search of improved clinical outcomes, according to […]
Cala Health touts results of real-world tremor study
Cala Health today touted data demonstrating that its Cala Trio therapy is safe and effective in improving essential tremor in patients. Burlingame, Calif.-based Cala Health said in a news release that the data for the wearable technology came from use at home, unsupervised and under real-world conditions, further validating the results reported in the Prospect […]
Report: China begins testing COVID-19 nasal spray vaccine
China has reportedly begun human testing for a COVID-19 vaccine which utilizes nasal spray instead of an injection. A report in Bloomberg cites a registration in the Chinese Clinical Trial Registry confirming that the nasal spray vaccine candidate developed by Xiamen University, Hong Kong University and Beijing Wantai Biological Pharmacy Enterprise is undergoing Phase I […]
COVID-19 antibody test shows promise in NIH-funded study
Researchers at The University of Texas at Austin are touting an accurate antibody test for COVID-19 with lower costs than those currently in use. According to a news release, the test, developed in collaboration with Houston Methodist and other institutions, is more accurate than the standard antibody tests in use right now and can handle […]
Medtronic TTVR system wins breakthrough device designation
Medtronic (NYSE:MDT) announced that it received FDA approval for an early feasibility study of its Intrepid TTVR system. Fridley, Minn.-based Medtronic’s Intrepid TTVR (transcatheter tricuspid valve replacement) system is designed for patients with severe, symptomatic tricuspid regurgitation, treating a diseased, damaged or malfunctioning valve that allows blood to flow back into the upper right chamber of […]
Medtronic study shows high rate of opioid-induced respiratory depression
Preliminary results from a new Medtronic (NYSE:MDT) study pinpoint a greater-than-previously measured rate of respiratory depression in patients receiving IV opioids for pain. The prospective, observational Prodigy study, which analyzed 1,335 patients across 16 sites in the U.S., Europe and Asia, found that respiratory depression, as defined by changes in pulse oximetry and capnography monitoring parameters, […]
- 1
- 2
- 3
- …
- 190
- Next Page »
